AMLX compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

AMLXAmylyx Pharmaceuticals, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

AMLXAmylyx Pharmaceuticals, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

AMLX

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±25.6%▲+10.71%×0.42

May 7 '26±11.9%▼−5.35%×0.45

Q1 FY26±17.6%▼−7.78%×0.44

Nov 6 '25±18.9%▼−5.89%×0.31

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

= impliedAMLX realized, solidLLY realized, hatchedOne scale, both sides: full bar = 26%× = |realized| ÷ impliedSource: market data

Q1 FY26

±5.3%

▲+9.80%

×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

AMLXAmylyx Pharmaceuticals, Inc.

27.59▼−6.15%· post 27.59· delayed

Mkt cap$3.8BRevenue$416,000Q3 FY24Revenue—

LLYELI Lilly & Co

1,371.32▼−3.29%· post 1,361.94· delayed

After hoursNov 5 '26delayed

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

After hoursNov 5 '26delayed

AMLXAmylyx Pharmaceuticals, Inc.

LLYELI Lilly & Co

27.59▼−6.15%post 27.59delayed

Price

1,371.32▼−3.29%post 1,361.94delayed

$3.8B

Mkt cap

$1.3T

Q3 FY24$416,000

Revenue

$24.4BQ3 FY26

—

Revenue

$65.2BFY25

AMLX27.59▼−6.15%vsLLY1,371.32▼−3.29%After hoursNov 5 '26delayed